Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit
Guardant claimed that a patent lawsuit filed against it by Illumina in March was filed in an inappropriate district court and is a “brazen attempt” to stifle competition.
Domus Diagnostics to Launch Point-of-Care Infectious Disease Molecular Diagnostics Test System
Premium
The Park City, Utah-based firm combines RT-LAMP with lyophilization and a scalable manufacturing system for its laminate card technology that keeps costs low.
Local Coverage Determinations Roundup: Castle Bio, SkylineDx
Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.
Europe is still struggling to meet the requirements of the regulation, which calls for the clearance of most tests by notified bodies before they can be sold for clinical use.
CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test
CorePath will develop and offer UK-based Cizzle's test in the US, with royalty agreements on all product and services offerings related to the test.